The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Fluoxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used for the treatment of major depressive disorder, obsessive–compulsive disorder (OCD), bulimia nervosa, panic disorder and premenstrual dysphoric disorder. It may decrease the risk of suicide in those over the age of 65.
The global Fluoxetine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Fluoxetine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fluoxetine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Fluoxetine include Teva, Sun Pharmaceutical, Sandoz, Mylan, Wockhardt, Dr.Reddy's Laboratories, Pharmaceutical Associates Inc., Lannett Company and Aurobindo Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Fluoxetine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluoxetine.
Report Scope
The Fluoxetine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fluoxetine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fluoxetine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Sun Pharmaceutical
Sandoz
Mylan
Wockhardt
Dr.Reddy's Laboratories
Pharmaceutical Associates Inc.
Lannett Company
Aurobindo Pharma
Alembic Pharmaceuticals
Alvogen
Torrent Pharmaceuticals
Suzhou YUSHI Pharmaceutical
Changzhou Siyao Pharmaceutical
Segment by Type
Tablets
Capsules
Oral Solution
Segment by Application
Depression
Obsessive–Compulsive Disorder
Panic Disorder
Bulimia Nervosa
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fluoxetine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fluoxetine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Fluoxetine is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used for the treatment of major depressive disorder, obsessive–compulsive disorder (OCD), bulimia nervosa, panic disorder and premenstrual dysphoric disorder. It may decrease the risk of suicide in those over the age of 65.
The global Fluoxetine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Fluoxetine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fluoxetine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Fluoxetine include Teva, Sun Pharmaceutical, Sandoz, Mylan, Wockhardt, Dr.Reddy's Laboratories, Pharmaceutical Associates Inc., Lannett Company and Aurobindo Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Fluoxetine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fluoxetine.
Report Scope
The Fluoxetine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fluoxetine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fluoxetine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Sun Pharmaceutical
Sandoz
Mylan
Wockhardt
Dr.Reddy's Laboratories
Pharmaceutical Associates Inc.
Lannett Company
Aurobindo Pharma
Alembic Pharmaceuticals
Alvogen
Torrent Pharmaceuticals
Suzhou YUSHI Pharmaceutical
Changzhou Siyao Pharmaceutical
Segment by Type
Tablets
Capsules
Oral Solution
Segment by Application
Depression
Obsessive–Compulsive Disorder
Panic Disorder
Bulimia Nervosa
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Fluoxetine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Fluoxetine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Fluoxetine Market Overview
1.1 Product Overview and Scope of Fluoxetine
1.2 Fluoxetine Segment by Type
1.2.1 Global Fluoxetine Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Oral Solution
1.3 Fluoxetine Segment by Application
1.3.1 Global Fluoxetine Market Value by Application: (2024-2030)
1.3.2 Depression
1.3.3 Obsessive–Compulsive Disorder
1.3.4 Panic Disorder
1.3.5 Bulimia Nervosa
1.3.6 Others
1.4 Global Fluoxetine Market Size Estimates and Forecasts
1.4.1 Global Fluoxetine Revenue 2019-2030
1.4.2 Global Fluoxetine Sales 2019-2030
1.4.3 Global Fluoxetine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fluoxetine Market Competition by Manufacturers
2.1 Global Fluoxetine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fluoxetine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fluoxetine Average Price by Manufacturers (2019-2024)
2.4 Global Fluoxetine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fluoxetine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fluoxetine, Product Type & Application
2.7 Fluoxetine Market Competitive Situation and Trends
2.7.1 Fluoxetine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fluoxetine Players Market Share by Revenue
2.7.3 Global Fluoxetine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fluoxetine Retrospective Market Scenario by Region
3.1 Global Fluoxetine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fluoxetine Global Fluoxetine Sales by Region: 2019-2030
3.2.1 Global Fluoxetine Sales by Region: 2019-2024
3.2.2 Global Fluoxetine Sales by Region: 2025-2030
3.3 Global Fluoxetine Global Fluoxetine Revenue by Region: 2019-2030
3.3.1 Global Fluoxetine Revenue by Region: 2019-2024
3.3.2 Global Fluoxetine Revenue by Region: 2025-2030
3.4 North America Fluoxetine Market Facts & Figures by Country
3.4.1 North America Fluoxetine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fluoxetine Sales by Country (2019-2030)
3.4.3 North America Fluoxetine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Fluoxetine Market Facts & Figures by Country
3.5.1 Europe Fluoxetine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fluoxetine Sales by Country (2019-2030)
3.5.3 Europe Fluoxetine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fluoxetine Market Facts & Figures by Country
3.6.1 Asia Pacific Fluoxetine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fluoxetine Sales by Country (2019-2030)
3.6.3 Asia Pacific Fluoxetine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Fluoxetine Market Facts & Figures by Country
3.7.1 Latin America Fluoxetine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fluoxetine Sales by Country (2019-2030)
3.7.3 Latin America Fluoxetine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fluoxetine Market Facts & Figures by Country
3.8.1 Middle East and Africa Fluoxetine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fluoxetine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fluoxetine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fluoxetine Sales by Type (2019-2030)
4.1.1 Global Fluoxetine Sales by Type (2019-2024)
4.1.2 Global Fluoxetine Sales by Type (2025-2030)
4.1.3 Global Fluoxetine Sales Market Share by Type (2019-2030)
4.2 Global Fluoxetine Revenue by Type (2019-2030)
4.2.1 Global Fluoxetine Revenue by Type (2019-2024)
4.2.2 Global Fluoxetine Revenue by Type (2025-2030)
4.2.3 Global Fluoxetine Revenue Market Share by Type (2019-2030)
4.3 Global Fluoxetine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fluoxetine Sales by Application (2019-2030)
5.1.1 Global Fluoxetine Sales by Application (2019-2024)
5.1.2 Global Fluoxetine Sales by Application (2025-2030)
5.1.3 Global Fluoxetine Sales Market Share by Application (2019-2030)
5.2 Global Fluoxetine Revenue by Application (2019-2030)
5.2.1 Global Fluoxetine Revenue by Application (2019-2024)
5.2.2 Global Fluoxetine Revenue by Application (2025-2030)
5.2.3 Global Fluoxetine Revenue Market Share by Application (2019-2030)
5.3 Global Fluoxetine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Fluoxetine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Fluoxetine Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Sun Pharmaceutical
6.2.1 Sun Pharmaceutical Corporation Information
6.2.2 Sun Pharmaceutical Description and Business Overview
6.2.3 Sun Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sun Pharmaceutical Fluoxetine Product Portfolio
6.2.5 Sun Pharmaceutical Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Fluoxetine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sandoz Fluoxetine Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Fluoxetine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Fluoxetine Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Wockhardt
6.5.1 Wockhardt Corporation Information
6.5.2 Wockhardt Description and Business Overview
6.5.3 Wockhardt Fluoxetine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Wockhardt Fluoxetine Product Portfolio
6.5.5 Wockhardt Recent Developments/Updates
6.6 Dr.Reddy's Laboratories
6.6.1 Dr.Reddy's Laboratories Corporation Information
6.6.2 Dr.Reddy's Laboratories Description and Business Overview
6.6.3 Dr.Reddy's Laboratories Fluoxetine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dr.Reddy's Laboratories Fluoxetine Product Portfolio
6.6.5 Dr.Reddy's Laboratories Recent Developments/Updates
6.7 Pharmaceutical Associates Inc.
6.6.1 Pharmaceutical Associates Inc. Corporation Information
6.6.2 Pharmaceutical Associates Inc. Description and Business Overview
6.6.3 Pharmaceutical Associates Inc. Fluoxetine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pharmaceutical Associates Inc. Fluoxetine Product Portfolio
6.7.5 Pharmaceutical Associates Inc. Recent Developments/Updates
6.8 Lannett Company
6.8.1 Lannett Company Corporation Information
6.8.2 Lannett Company Description and Business Overview
6.8.3 Lannett Company Fluoxetine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lannett Company Fluoxetine Product Portfolio
6.8.5 Lannett Company Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Corporation Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Fluoxetine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Aurobindo Pharma Fluoxetine Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 Alembic Pharmaceuticals
6.10.1 Alembic Pharmaceuticals Corporation Information
6.10.2 Alembic Pharmaceuticals Description and Business Overview
6.10.3 Alembic Pharmaceuticals Fluoxetine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Alembic Pharmaceuticals Fluoxetine Product Portfolio
6.10.5 Alembic Pharmaceuticals Recent Developments/Updates
6.11 Alvogen
6.11.1 Alvogen Corporation Information
6.11.2 Alvogen Fluoxetine Description and Business Overview
6.11.3 Alvogen Fluoxetine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Alvogen Fluoxetine Product Portfolio
6.11.5 Alvogen Recent Developments/Updates
6.12 Torrent Pharmaceuticals
6.12.1 Torrent Pharmaceuticals Corporation Information
6.12.2 Torrent Pharmaceuticals Fluoxetine Description and Business Overview
6.12.3 Torrent Pharmaceuticals Fluoxetine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Torrent Pharmaceuticals Fluoxetine Product Portfolio
6.12.5 Torrent Pharmaceuticals Recent Developments/Updates
6.13 Suzhou YUSHI Pharmaceutical
6.13.1 Suzhou YUSHI Pharmaceutical Corporation Information
6.13.2 Suzhou YUSHI Pharmaceutical Fluoxetine Description and Business Overview
6.13.3 Suzhou YUSHI Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Suzhou YUSHI Pharmaceutical Fluoxetine Product Portfolio
6.13.5 Suzhou YUSHI Pharmaceutical Recent Developments/Updates
6.14 Changzhou Siyao Pharmaceutical
6.14.1 Changzhou Siyao Pharmaceutical Corporation Information
6.14.2 Changzhou Siyao Pharmaceutical Fluoxetine Description and Business Overview
6.14.3 Changzhou Siyao Pharmaceutical Fluoxetine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Changzhou Siyao Pharmaceutical Fluoxetine Product Portfolio
6.14.5 Changzhou Siyao Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fluoxetine Industry Chain Analysis
7.2 Fluoxetine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fluoxetine Production Mode & Process
7.4 Fluoxetine Sales and Marketing
7.4.1 Fluoxetine Sales Channels
7.4.2 Fluoxetine Distributors
7.5 Fluoxetine Customers
8 Fluoxetine Market Dynamics
8.1 Fluoxetine Industry Trends
8.2 Fluoxetine Market Drivers
8.3 Fluoxetine Market Challenges
8.4 Fluoxetine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
